Perampanel Tablet, Film Coated
NDC Package 51672-4205-2
Package Information
Perampanel tablets is perampanel is used to treat certain types of seizures (including focal and generalized tonic-clonic seizures). This formulation utilizes a tablet, film coated delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-4205 and is authorized under FDA application ANDA209538.
Identification & Billing
- RxCUI: 1356557 - perampanel 2 MG Oral Tablet
- RxCUI: 1356570 - perampanel 4 MG Oral Tablet
- RxCUI: 1356574 - perampanel 6 MG Oral Tablet
- RxCUI: 1356578 - perampanel 8 MG Oral Tablet
- RxCUI: 1356582 - perampanel 10 MG Oral Tablet
Clinical Specifications
- AMPA Receptor Antagonists - [MoA] (Mechanism of Action)
- Cytochrome P450 2C8 Inhibitors - [MoA] (Mechanism of Action)
- Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
- Noncompetitive AMPA Glutamate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- UGT1A9 Inhibitors - [MoA] (Mechanism of Action)
- UGT2B7 Inhibitors - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-4205 - Perampanel
- 51672-4205-2 - 3 BLISTER PACK in 1 CARTON / 10 TABLET, FILM COATED in 1 BLISTER PACK
- 51672-4205 - Perampanel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51672-4205). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-4205-2 identifies a specific commercial package of 3 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack of Perampanel, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This tablet, film coated is formulated for oral use and contains perampanel as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on November 25, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Perampanel is used to treat certain types of seizures (including focal and generalized tonic-clonic seizures). Perampanel belongs to a class of drugs known as anticonvulsants.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672420502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.